REATA PHARMACEUTICALS INC-A (RETA)
US75615P1030 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 48.84M | 42.31M | 590.26M | 818.20M | 664.30M | |||
| Marketable Securities | 281.37M | 345.20M | N/A | N/A | N/A | |||
| Receivables | 22.66M | N/A | 0.00 | 22.20M | N/A | |||
| Inventories | 2.94M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 46.03M | 10.26M | 6.22M | 7.00M | 5.00M | |||
| Total Current Assets | 401.85M | 397.77M | 596.48M | 847.30M | 669.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 89.90M | 116.44M | 138.38M | 10.10M | 12.10M | |||
| Other Non-Current Assets | 10.84M | 284.00K | 160.00K | 100.00K | 1.10M | |||
| Total Non-Current Assets | 100.74M | 116.72M | 138.54M | 10.30M | 13.10M | |||
| TOTAL ASSETS | 502.59M | 514.49M | 735.02M | 857.60M | 682.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 73.40M | 150.00M | |||
| Accrued Expenses | 27.59M | 15.99M | 17.39M | 16.90M | 26.90M | |||
| Accounts Payable | 19.86M | 18.71M | 13.51M | 4.80M | 1.90M | |||
| Other Current Liabilities | 77.64M | 24.27M | 23.10M | 24.10M | 13.20M | |||
| Total Current Liabilities | 125.09M | 58.96M | 53.99M | 119.20M | 192.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 73.13M | 0.00 | 0.00 | 0.00 | 221.90M | |||
| Other Non-Current Liabilities | 217.07M | 521.23M | 495.03M | 321.00M | 11.70M | |||
| Total Non-Current Liabilities | 290.20M | 521.23M | 495.03M | 321.00M | 233.60M | |||
| TOTAL LIABILITIES | 415.30M | 580.19M | 549.03M | 440.20M | 425.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.49B | -1.57B | -1.26B | -958.20M | -710.50M | |||
| Additional Paid In Capital | 1.58B | 1.50B | 1.44B | 1.38B | 967.30M | |||
| Common Shares | 38.00K | 37.00K | 36.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 37.85M | 36.68M | 36.40M | 36.20M | 33.20M | |||
| Tangible Book Value per Share | 2.31 | -1.79 | 5.11 | 11.53 | 7.74 | |||
| Total Shareholders' Equity | 87.29M | -65.69M | 185.99M | 417.40M | 256.90M | |||
| TOTAL LIABILITIES AND EQUITY | 502.59M | 514.49M | 735.02M | 857.60M | 682.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.84 | N/A | N/A | N/A | 0.86 | |||
| Current Ratio | 3.21 | 6.75 | 11.05 | 7.11 | 3.49 | |||
| Return On Assets (ROA) | -17.43% | -60.62% | -40.46% | -28.89% | -42.52% | |||
| Return On Equity (ROE) | -100.38% | N/A | -159.89% | -59.36% | -112.95% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD